Life-saving HIV drugs risk running out as COVID-19 hits supplies: WHO

LONDON (Reuters) - More than a third of the world's countries say they are at risk of running out of life-saving AIDS drugs because of disruptions to supply lines and other problems caused by the COVID-19 pandemic, the World Health Organization said on Monday. Twenty-four out of those 73 nations have already reported critically low supplies of the vital antiretroviral drugs, the agency said

Reuters July 07, 2020 00:12:35 IST
Life-saving HIV drugs risk running out as COVID-19 hits supplies: WHO

COVID-19 hits supplies: WHO" src="https://images.firstpost.com/wp-content/uploads/reuters/07-2020/07/2020-07-06T180424Z_1_LYNXMPEG651FT_RTROPTP_2_HEALTH-CORONAVIRUS-AIDS-DRUGS.jpg" alt="Lifesaving HIV drugs risk running out as COVID19 hits supplies WHO" width="300" height="225" />

LONDON (Reuters) - More than a third of the world's countries say they are at risk of running out of life-saving AIDS drugs because of disruptions to supply lines and other problems caused by the COVID-19 pandemic, the World Health Organization said on Monday.

Twenty-four out of those 73 nations have already reported critically low supplies of the vital antiretroviral drugs, the agency said.

"The findings of this survey are deeply concerning," the WHO's director general Tedros Adhanom Ghebreyesus said in a statement at the start of the International AIDS conference.

"We cannot let the COVID-19 pandemic undo the hard-won gains in the global response to this disease."

The WHO said about 8.3 million HIV-positive people are reliant on the antiretroviral drugs in the 24 worst-hit states - about a third of all people taking HIV treatment globally.

It did not name the affected countries in its survey.

While there is no cure for the human immunodeficiency virus that causes AIDS, drugs known as antiretrovirals (ARVs) can control the virus and prevent HIV-positive people from transmitting it via sex to others.

About 38 million people worldwide are currently infected with HIV.

The survey found that during the ongoing COVID-19 outbreak, a failure of suppliers to deliver ARVs on time, combined with drastically reduced land and air transport and limited access to health services, have caused major disruptions to drug supplies.

The WHO has issued guidance on maintaining access to essential health services, such as HIV treatment and testing clinics, during the pandemic. It says health authorities should consider "multi-month dispensing" for AIDS drugs - a policy whereby medicines are prescribed for up to six months.

(Reporting by Kate Kelland, editing by Andrew Heavens)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

Alphabet's Waymo partners with Google Maps to offer autonomous rides
Business

Alphabet's Waymo partners with Google Maps to offer autonomous rides

(Reuters) - Alphabet Inc's self-driving unit Waymo said on Thursday it had partnered with Google's Maps to let users book fully autonomous ride-hailing services through the app.

Tesla revises plans for German gigafactory with more details on product lines
Business

Tesla revises plans for German gigafactory with more details on product lines

FRANKFURT (Reuters) - Tesla on Thursday revised its application for a planned gigafactory in Europe to include details for plans to produce battery cells on site and an expansion of other production lines, German officials said. It also includes plans to reduce water consumption so that usage remains constant compared to earlier proposals despite the expansion. Tesla has sharply criticised the lengthy regulatory processes in Germany and has pushed back the factory's opening date.

Facebook ready to commit to clear ad data access for partners, French watchdog says
Business

Facebook ready to commit to clear ad data access for partners, French watchdog says

By Mathieu Rosemain PARIS (Reuters) - U.S. social media giant Facebook has offered to commit to providing its partners with clear and objective conditions of access to advertising inventories and ad campaign data, France's antitrust authority said on Thursday following an investigation.